Fundraising FoxCorindus Vascular Robotics
Waltham, US · Founded 2011 · Delaware corporation · 3 known investors
Find your way into Corindus Vascular Robotics
Sign up to see every warm intro you have to Corindus Vascular Robotics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Corindus Vascular Robotics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SJ
Stephen J. LemasterExecutive
MJ
Mark J. TolandPresident and CEO2016–2020Mark Toland is CEO of MMI SpA, having previously served as President and CEO of Corindus Vascular Robotics, which was acquired by Siemens Healthineers. He previously held the role of Senior Vice President at Boston Scientific, where he oversaw cardiovascular commercial operations, and holds a Bachelor of Science in Business Administration from the University of Louisville.
DW
David W. LongExecutive
DM
David M HandlerExecutive
Board
JC
Jeffrey C. LightcapBoard director
LA
GW
Gerard WinkelsBoard director
HB
DW
David WhiteBoard director
CD
Campbell D. RogersBoard director
JG
Jeffrey G. GoldBoard director
MM
Michael MashaalBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$117.1M disclosed across 7 rounds · 2014–2019
▶$4.8MraisedMar 2019 · 3 investors · Other Health CareRule 506(b)
▶$4.8MraisedMar 2019 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas TeanyExecutive Officer
- Nathan R. HarringtonDirector
- James R. TobinDirector
- Campbell D. RogersDirector
- David W. LongExecutive Officer
- Mark J. TolandExecutive Officer, Director
- Douglas L. BraunsteinDirector
- Jeffrey G. GoldDirector
- Louis A. CannonDirector
- Jeffrey C. LightcapDirector
- Offering amount
- $4.8M
- Amount sold
- $4.8M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$413.9KraisedMar 2019 · 2 investors · Other Health CareRule 506(b)
▶$413.9KraisedMar 2019 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas TeanyExecutive Officer
- Campbell D. RogersDirector
- Nathan R. HarringtonDirector
- Douglas L. BraunsteinDirector
- Jeffrey C. LightcapDirector
- Jeffrey G. GoldDirector
- Mark J. TolandExecutive Officer, Director
- David W. LongExecutive Officer
- James R. TobinDirector
- Louis A. CannonDirector
- Offering amount
- $413.9K
- Amount sold
- $413.9K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedMar 2019 · 1 investors · Other Health CareRule 506(b)
▶$15MraisedMar 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey C. LightcapDirector
- Douglas TeanyExecutive Officer
- David W. LongExecutive Officer
- Campbell D. RogersDirector
- James R. TobinDirector
- Nathan R. HarringtonDirector
- Douglas L. BraunsteinDirector
- Mark J. TolandExecutive Officer, Director
- Louis A. CannonDirector
- Jeffrey G. GoldDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedMar 2018 · 4 investors · Other Health CareRule 506(b)
▶$25MraisedMar 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey G. GoldDirector
- Douglas L. BraunsteinDirector
- Campbell D. RogersDirector
- Nthan R. HarringtonDirector
- Jeffrey C. LightcapDirector
- Mark J. TolandExecutive Officer, Director
- David W. LongExecutive Officer
- Louis A. CannonDirector
- James R. TobinDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$180KraisedMar 2018 · 2 investors · Other Health CareRule 506(b)
▶$180KraisedMar 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas L. BraunsteinDirector
- James R. TobinDirector
- Jeffrey C. LightcapDirector
- Jeffrey G. GoldDirector
- Nathan R. HarringtonDirector
- Campbell D. RogersDirector
- Louis A. CannonDirector
- David W. LongExecutive Officer
- Mark J. TolandExecutive Officer, Director
- Offering amount
- $180K
- Amount sold
- $180K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45MraisedMar 2017 · 16 investors · Other Health CareRule 506(b)
▶$45MraisedMar 2017 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey C. LightcapDirector
- Campbell D. RogersDirector
- Stephen J. LemasterExecutive Officer
- Louis A. CannonDirector
- Mark J. TolandExecutive Officer, Director
- Jeffrey G. GoldDirector
- David W. LongExecutive Officer
- Gerard WinkelsDirector
- Offering amount
- $45M
- Amount sold
- $45M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26.7MraisedSep 2014 · 15 investors · Other Health CareRule 506(c)
▶$26.7MraisedSep 2014 · 15 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Jeffrey C LightcapDirector
- David W LongExecutive Officer
- Michael MashaalDirector
- Jeffrey GoldDirector
- David M HandlerExecutive Officer, Director
- Gerard WinkelsDirector
- Hillel BachrachDirector
- David WhiteDirector
- Offering amount
- $26.7M
- Amount sold
- $26.7M
- Minimum investment
- $100K
- Sales commissions
- $1M
- Placement agents
- Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated
- First sale
- Sep 2014
- Incorporated
- Corporation, Nevada, 2011
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Corindus Vascular Robotics's investors?
- Corindus Vascular Robotics's investors include 20/20 HealthCare Partners LLC, BioStar Ventures, Healthcare Venture Partners, Llc.
- How much funding has Corindus Vascular Robotics raised?
- Corindus Vascular Robotics has disclosed $117.1M raised across 7 rounds.
- Where is Corindus Vascular Robotics headquartered?
- Corindus Vascular Robotics is headquartered in Waltham, US.